Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00262782
Status:
COMPLETED
Last Update Posted:
2020-02-20
First Post:
2005-12-06
Brief Title:
Fludarabine or Observation in Treating Patients With Stage 0 Stage I or Stage II Chronic Lymphocytic Leukemia
Sponsor:
German CLL Study Group
Organization:
German CLL Study Group
Organization Data
Organization:
German CLL Study Group
Class:
OTHER
Study ID:
CLL1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
German CLL Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None